We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTPG.L Regulatory News (TPG)

  • There is currently no data for TPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

21 Sep 2022 07:00

RNS Number : 0575A
TP Group PLC
21 September 2022
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

21 September 2022

 

TP Group plc

("TP Group" or the "Company" or the "Group")

 

UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2022

 

 

 

· TPG Services division operating in line with management expectations

· TPG Maritime division impacted by continuing renegotiation of legacy onerous contracts

· Disposal of Sapienza and Northstar during the period

· Discussions with a potential acquirer of Westek continue

· H1 2022 closing net debt at 30 June 2022 was £4.3m (Dec 2021 net debt: £1.6m)

 

For further information, please contact:

 

Martyn Ratcliffe, Chairman

Derren Stroud, Chief Financial Officer

 

Tel: 01753 285802

www.tpgroupglobal.com

 

 

 

Cenkos Securities plc

Tel: 020 7397 8980

Stephen Keys / Mark Connelly / Callum Davidson

 

www.cenkos.com

 

 

 

 

Business Review

TP Group is a consulting and engineering business operating primarily in the UK defence and aerospace markets. The Group comprises two operating divisions: TPG Services and TPG Maritime.

 

Comparisons to H1 2021 are before the additional provisions and charges that were accounted for in the 2021 full year results. In view of the current priorities, the Board consider that analysis of these 2021 adjustments and assessment of the exact timing of these adjustments through the year would be costly and of little benefit to shareholders. Therefore the 2021 comparisons are provided before the adjustments recorded for the full year and readers are referred to the Group's Annual Report for 2021. The H1 2021 results however, have been restated to take into account the impacts of the 2020 prior period adjustments. These adjustments have a roll forward impact on the H1 2021 results which the business has been able to quantify and account for accordingly. As noted above, the readers are referred to the Group's Annual Report for 2021 for details of the 2020 prior year adjustments.

 

For the six months ended 30 June 2022 the Group reported revenue from continuing operations of £24.3m (H1 2021 restated: £23.5m) and adjusted operating profit of £1.3m (H1 2021 restated: £0.9m). The operating loss from continuing operations was £0.3m (2021 operating loss restated: £1.7m) and the statutory loss, which includes discontinued operations, was £0.2m (H1 2021 statutory loss restated: £2.8m).

 

The Group's net debt position on 30 June 2022 was £4.3m (31 December 2021 net debt: £1.6m). The £5m Science Group facility was undrawn at the date of this announcement. Whilst drawdowns have occurred during the period, the funds have not been required and have been repaid to Science Group. However, the Board are forecasting utilising the Science Group facility in the coming months. The HSBC loan facility was fully drawn on 30 June 2022 and remained fully drawn at the date of this announcement. The HSBC facility reduced from £7m to c.£6m on 12 July 2022, following the repayment of c.£1m from the net disposal proceeds from the sale of Sapienza. As noted in the full year results, the Board will shortly be commencing a refinancing exercise including discussions with its bank to extend or renew the facility. The Board are not anticipating that the Science Group facility will be extended beyond September 2023.

 

TPG Services

The TPG Services Division delivers technical expertise to complex and critical major government sponsored programmes in the defence and aerospace sectors. Osprey, the aviation safety consulting business acquired in 2020, is now being integrated into TPG Services existing consultancy business.

 

The TPG Services division has continued to enjoy success through the first half of the year performing in-line with management's expectations. For the six months ended 30 June 2022, TPG Services delivered revenue of £14.3m (H1 2021: £12.8m), organic growth of 12%. Adjusted operating profit increased to £1.5m (H1 2021: £0.9m).

 

TPG Maritime

TPG Maritime designs, manufactures and supports life support systems for submarine programmes including oxygen production and the removal of toxic gases.

 

The division has had a slower start to 2022 due to the previously reported challenges relating to onerous legacy contracts and the resources required in renegotiating commercial terms. Order intake, revenue and profit metrics are all below management's expectations for the year-to-date. Resolving these legacy contracts is the Board's key priority and a corporate imperative in light of the refinancing requirement noted above. In the first half of 2022, a new management team was installed within the division to effect the necessary changes, including a general manager seconded from Science Group and the recruitment of a finance manager, supported by a strengthened operational management team.

 

For the six months ended 30 June 2022, the TPG Maritime Division reported revenue of £10.0m (H1 2021 restated: £10.7m) and an adjusted operating profit of £0.3m (H1 2021 restated: £0.8m). The negative impact of the legacy contracts will continue to affect the division's financial performance for at least the remainder of the current year and the next.

 

Due to the materiality of the onerous legacy contracts, the ability of TP Maritime Limited, the operating subsidiary, to continue to operate as a going concern is dependent on the continuing financial support of TP Group plc. The Board recognise that this onerous legacy may impact the Group's refinancing discussions referenced above.

 

Corporate

In the first half of 2022, the Board has executed the Group strategy set out in November 2021 to focus on its UK-based defence and aerospace operations. Accordingly, the Board disposed of two of its non-core business activities: Northstar in March 2022 and Sapienza in July 2022. Westek continues to operate profitably and discussions with a potential acquirer continue. As noted above, half of the disposal proceeds (c£1.0m) from the sale of Sapienza have been used to reduce the HSBC debt facility to c£6.0m.

Summary and outlook

This period has continued to see mixed fortunes across TP Group's divisions as TPG Services enjoys both growth and increasing profitability while TPG Maritime's performance remains hampered by the legacy contracts.

In summary, 2022 and 2023 will be a period of transition for TP Group, critically dependent on the resolution of both the legacy contracts in TPG Maritime and the Group's financing/capital structure, matters which may be inter-related.

 

 

 

Condensed consolidated statement of comprehensive income

 

  

Six months ended

30 June

2022

 

(Unaudited)1

 

Six months ended

30 June

2021

(restated)

(Unaudited)1

 

Year ended

31 December

2021

 

(Audited)

 

 

£'000

£'000

£'000

Revenue from continuing operations

24,330

23,496

44,255

Cost of sales

(19,113)

(18,250)

(37,350)

Gross profit from continuing operations

5,217

5,246

6,905

Administrative expenses

(5,495)

(6,985)

(14,405)

Operating loss from continuing operations

(278)

(1,739)

(7,500)

Operating loss from continuing operations

(278)

(1,739)

(7,500)

Depreciation, amortisation and impairment

988

1,284

3,129

Acquisition-related costs

-

140

(40)

Exceptional operating costs

599

531

1,875

Gain on disposal of assets

-

-

(23)

Share-based payments expense

6

34

164

Movement in expected earn-out payments

-

631

830

Adjusted operating profit / (loss) from continuing operations

1,315

881

(1,565)

Net finance costs

(343)

(129)

(450)

Loss before taxation from continuing operations

(621)

(1,868)

(7,950)

Taxation credit

91

122

59

Loss for the period from continuing operations

(530)

(1,746)

(7,891)

Profit / (loss) for the period from discontinued operations (attributable to equity holders of the company)

311

(1,065)

(11,138)

Loss for the period attributable to equity holders of the parent company

(219)

(2,811)

(19,029)

Other comprehensive income/(expense) for the period:

Loss for the period

(219)

(2,811)

(19,029)

Foreign exchange (losses) / gains on translation of foreign operations

(36)

65

(481)

Total comprehensive expense for the period attributable to equity holders of the parent company

(255)

(2,746)

(19,510)

 

Earnings per share:

Loss per share (pence per share)

Continuing operations:

Basic and diluted loss per share (pence per share)

(0.07)

(0.22)

(1.01)

Discontinued operations:

Basic and diluted profit / (loss) per share (pence per share)

0.04

(0.14)

(1.43)

Total:

Basic and diluted loss per share (pence per share)

(0.03)

(0.36)

(2.44)

1 The six-month periods to June 2022 and June 2021 have been presented to reflect continuing operations and exclude the results of Northstar (disposed of in March 2022), Sapienza Consulting Holdings BV (disposed of in July 2022) and Westek Technology Limited (asset held for sale at the balance sheet date). The results for Northstar, Sapienza and Westek are presented above as 'profit / (loss) for the period from discontinued operations'. The six-month period to June 2021 has also been presented to reflect the impact of the 2020 prior year adjustments as referred to in the Group's Annual Report for 2021. Refer to note 7 for further details.

 

2 Adjusted operating profit / (loss) is defined as operating result adjusted to add back depreciation of property, plant and equipment and right-of-use assets, amortisation of intangible assets and impairment gains or losses on non-current assets, acquisition consideration accounted for as employment costs owing to ongoing service conditions, any acquisition-related charges, share-based payment charges and exceptional operating costs. The directors believe this measure is more reflective of the underlying performance of the Group than equivalent Generally Accepted Accounting Practice ('GAAP') measures because it is excludes non-recurring exceptional and acquisition costs, non-cash items and is therefore a better proxy for underlying operating cash, providing shareholders and other users of the financial statements with the most representative year-on-year comparison of underlying operational performance attributable to shareholders.

 

 

Condensed consolidated statement of financial position

 

30 June

2022

 

(Unaudited)

 

30 June

2021

(restated)

(Unaudited)

 

31 December

2021

 

(Audited)

 

£'000

£'000

£'000

Assets

Non-current assets

Goodwill

4,338

8,091

4,338

Other intangible assets

7,324

18,521

7,978

Property, plant and equipment

522

920

591

Right-of-use assets

2,270

3,471

2,485

 Total non-current assets

14,454

31,003

15,392

 

Current assets

Inventories

383

1,820

416

Trade and other receivables

3,494

10,469

4,512

Amounts due from contract customers

6,428

8,649

5,599

Taxation recoverable

107

143

258

Cash and bank balances

2,653

3,480

5,376

13,065

24,561

16,161

Assets held for sale1

7,740

-

8,170

Total current assets

20,805

24,561

24,331

Total assets

35,259

55,564

39,723

 

Liabilities

Current liabilities

Trade and other payables

(7,684)

(14,408)

(11,154)

Amounts due to contract customers

(4,594)

(5,360)

(5,173)

Lease liabilities

(310)

(619)

(424)

(12,588)

(20,387)

(16,751)

Liabilities held for sale1

(6,642)

-

(6,326)

Total current liabilities

(19,230)

(20,387)

(23,077)

 

Non-current liabilities

Deferred taxation

(1,315)

(2,766)

(1,403)

Lease liabilities

(2,518)

(3,657)

(2,752)

Borrowings

(7,000)

(7,000)

(7,000)

Provisions

(561)

(235)

(607)

Total non-current liabilities

(11,394)

(13,658)

(11,762)

Total liabilities

(30,624)

(34,045)

(34,839)

Net assets

4,635

21,519

4,884

Equity

Share capital

7,792

7,792

7,792

Share premium

18,529

18,529

18,529

Own shares held by EBT

-

(561)

-

Translation of foreign operations

(146)

475

(90)

Share-based payments reserve

285

720

553

Retained earnings

(21,826)

(5,437)

(21,901)

Total equity due to shareholders

4,634

21,518

4,883

Non-controlling interest

1

1

1

Total equity

4,635

21,519

4,884

1 Includes the assets and liabilities for Northstar (disposed of in March 2022), Sapienza Consulting Holdings BV (disposed of in July 2022) and Westek Technology Limited (asset held for sale at the balance sheet date).

Condensed consolidated statement of changes in equity

 

Share capital

Share premium

Own shares held by EBT

Share-based payments reserve

Translation reserve

Retained earnings

Non-controlling interest

Total

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Balance at 1 January 2021

7,792

18,529

(561)

685

415

131

1

26,992

Adjustment to prior period

-

-

-

-

-

(2,762)

-

(2,762)

Balance at 1 January 2021 (restated)

 

7,792

18,529

(561)

685

415

(2,631)

1

24,230

Loss for the period (restated)

-

-

-

-

-

(2,811)

-

(2,811)

Other comprehensive gain

 

-

-

-

-

65

-

-

65

Total comprehensive gain / (loss)

-

-

-

-

65

(2,811)

-

(2,746)

Share-based payments charge

 

-

-

-

35

-

-

-

35

Forex movement

-

-

-

-

(5)

5

-

-

Balance at 30 June 2021

7,792

18,529

(561)

720

475

(5,437)

1

21,519

Balance at 1 July 2021

7,792

18,529

(561)

720

475

(5,437)

1

21,519

Loss for the period

-

-

-

-

-

(16,218)

-

(16,218)

Other comprehensive loss

-

-

-

-

(546)

-

-

(546)

Total comprehensive loss

-

-

-

-

(546)

(16,218)

-

(16,764)

Share-based payments charge

 

-

-

-

129

-

-

-

129

Share-based payments reserves transfer

 

-

-

-

(296)

-

296

-

-

Forex movement

 

-

-

-

-

(19)

19

-

-

Release in closure of EBT

-

-

-

-

561

-

-

(561)

-

-

Balance at 31 December 2021

7,792

18,529

-

553

(90)

(21,901)

1

4,884

Balance at 1 January 2022

7,792

 18,529

-

553

(90)

(21,901)

1

4,884

Loss for the period

-

-

-

-

-

(219)

-

(219)

Other comprehensive loss

 

-

-

-

-

(36)

-

-

(36)

Total comprehensive gain loss

-

-

-

-

(36)

(219)

-

(255)

Share-based payments charge

 

-

-

-

6

-

-

-

6

Share-based payments reserves transfer

 

-

-

-

(274)

-

274

-

-

Forex movement

-

-

-

-

(20)

20

-

-

Balance at 30 June 2022

7,792

18,529

-

285

(146)

(21,826)

1

4,635

Condensed consolidated statement of cash flows

 

Six months ended

30 June

2022

 

 

(Unaudited)

 

Six months ended

30 June

2021

(restated)

 

(Unaudited)

 

Year ended

31 December

2021

 

 

(Audited)

 

£'000

£'000

£'000

Operating activities

Loss before income tax from continuing operations

(621)

(1,869)

(7,950)

Profit / (loss) before income tax from discontinued operations

375

(1,186)

(12,459)

Total loss before taxation

(246)

(3,055)

(20,409)

Adjustments for:

Depreciation, amortisation and impairment

1,288

2,260

4,918

Finance cost

377

146

512

Share-based payment expense

6

34

164

Impairment (release) / loss on available-for-sale assets

(620)

-

10,572

Loss on disposal of subsidiary

(46)

-

(129)

(Increase) / decrease in inventories

(94)

(404)

698

Decrease / (increase) in trade and other receivables

734

(1,456)

1,802

(Decrease) / increase in trade and other payables

(3,615)

(98)

1,605

(Decrease) / increase in provisions

(68)

(117)

421

(2,284)

(2,690)

154

Taxation credit

225

103

77

Net cash (used in) / generated from operating investing activities

 

 

 

activities

(2,059)

(2,587)

231

Purchase of property, plant and equipment

(75)

(143)

(286)

Purchase of intangible fixed assets

(264)

(529)

(964)

Disposal of subsidiary, net of cash disposed of

567

-

135

Net cash generated / (used in) investing activities

228

(672)

(1,115)

Financing activities

Interest payable

(377)

(146)

(354)

Loan arrangement fee

-

-

(150)

Repayment of lease liabilities

(510)

(493)

(598)

Net cash used in financing activities

(887)

(639)

(1,102)

Effect of exchange rates on cash and cash equivalents

(5)

6

(10)

Net (decrease) / increase in cash and cash equivalents

(2,723)

(3,892)

(1,996)

Cash and cash equivalents at the beginning of the period

5,376

7,372

7,372

Cash and cash equivalents at the end of the period

2,653

3,480

5,376

 

 

 

 

 

 

Notes to the condensed set of unaudited interim financial statements

 

1. General information

TP Group plc (the 'Group') together with its subsidiaries is a consulting and engineering business operating primarily in the UK defence and aerospace markets.

 

The Group is incorporated under the Companies Act and domiciled in the United Kingdom. The address of the registered office of the Parent Company is Cale House, Station Road, Wincanton, BA9 9FE. The Company's shares are listed on the Alternative Investment Market of the London Stock Exchange

 

2. Basis of preparation

The financial information for the six months ended 30 June 2022 presented in these unaudited condensed consolidated interim financial statements (the 'interim report') has been measured and presented in sterling which is the currency of the primary economic environment in which the Group operates. They have been prepared under the historical cost convention, except for, where applicable, the revaluation of financial assets and liabilities at fair value through profit or loss, financial assets at fair value through other comprehensive income, or when an impairment is recognised on non-current assets. Figures are presented to the nearest thousand pounds, unless otherwise stated.

 

The consolidated financial statements have been prepared in accordance with UK adopted international accounting standards and interpretations issued by the International Financial Reporting Standards Interpretations Committee applicable to companies reporting under IFRS. The financial statements comply with International Financial Reporting Standards as adopted by the UK ("IFRS").

 

The financial information set out in this interim report does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The Group's statutory financial statements for the year ended 31 December 2021, prepared under International Financial Reporting Standards as adopted by the UK ("IFRS"), have been delivered to the Registrar of Companies. The auditor's report on the 2021 financial statements was unqualified, did not contain a statement under Section 498(2) or Section 498(3) of the Companies Act 2006 but did draw attention to a material uncertainty related to going concern. The audit opinion was not modified in respect of this matter.

 

These unaudited condensed consolidated interim financial statements were approved for issue by the Board of Directors on 20 September 2022.

 

Going Concern

As part of the going concern assessment, the directors have considered:

· various scenarios for the business for the period through to 31 December 2023, including delivery of its base case budget through 2022 and 2023, and downside sensitivities to this budget, as noted below.

· the Group's sources of committed external financing and related covenants.

 

The Group's debt facilities at the time of this announcement are:

· A £6m HSBC Bank loan facility which was fully drawn at the time of signing these accounts.

· A £5m loan facility secured from Science Group plc in December 2021. The loan was undrawn at the balance sheet date and the balance was nil at the time of this RNS.

Both facilities terminate in September 2023. The Board will commence a process in the second half of 2022 to refinance the Group and will consider both debt and equity options.

In addition to its debt facilities, the Company could raise additional equity capital through its listing on the AIM, although is mindful that the ongoing market environment could impact any fundraising potential. The Company is currently able to raise up to 10% of its market capitalisation through an equity placing on a non pre-emptive basis without the need for shareholder approval. Accordingly, the directors believe that the Company would be able to react with reasonable speed in the event it was required to pursue this course of action, subject to market conditions.

 

The directors regularly review operating performance and cash generation projections for the Group which are based on delivery of the Group's order book, a reasonable expectation of success in ongoing and future bids for further contracts and an expectation of additional work from current and new customers. A base case budget and cash flow projection has been prepared for 2022 and 2023, covering at least the 12-month period following the signing of the Group accounts. The base case budget provides sufficient liquidity and bank covenant compliance throughout the period.

The business however continues to navigate through the consequential effects of COVID-19, most notably the challenges in supply chains and logistics, and the onerous legacy TPG Maritime contracts. Furthermore, whilst the Group has no trade or activity in Ukraine or Russia, it is mindful of the impact that the conflict may have on global supply chains and the timing of new business opportunities.

As such, the consequences of the above may further delay the timely execution of both the Group's order book and new order wins which could result in revenue, margins and resulting cash inflows, that are less and/or later than modelled, putting pressure on the Group's cash and covenant position at times. The directors have therefore flexed and stress tested the base case budget to account for various operating scenarios, the outcomes of which include:

· a 20% reduction in revenue;

· a reduction of 6% in the Group's gross margin percentage;

· a deterioration in working capital cash conversion of £2.3m in 2022 and £7.9m in 2023; and

· a blend of the above.

These scenarios assume similar and/or greater levels of disruption to the Group's business to those experienced to date since the onset of the COVID-19 pandemic, despite conditions improving and as a result of the onerous legacy TPG Maritime contracts. All the scenarios take into account the cash and debt facilities currently available to the Company.

The directors have reviewed the Group's overall position and outlook in respect of the matters identified, including the scenarios noted above, and are of the opinion that there are reasonable grounds to believe that the operational and financial projections are achievable, and that the base case budget provides insulation to a plausible downside scenario. Accordingly, the directors have a reasonable expectation that the Group will have adequate resources to meet its obligations as and when they fall due for the foreseeable future and are satisfied that it is appropriate to prepare the financial statements for the Group on a going concern basis.

However, considering all of the above factors, the directors have concluded that if a more extreme but plausible down-side scenario arises the Group could breach one or more of its covenants in the 12-month period following approval of the financial statements. In this scenario, the business would be reliant on either securing a waiver from both HSBC Bank and Science Group or securing additional funding/debt headroom. Both HSBC Bank and Science Group have been supportive of the business through to this point and, whilst the Board cannot guarantee a waiver will be forthcoming, would consider it reasonable to conclude that agreement could be reached with the parties. For the avoidance of doubt, Martyn Ratcliffe and Peter Bertram would recuse themselves from discussions with Science Group in relation to their loan facility.

Furthermore, the Company could also look to raise additional capital through either or both, a 10% direct equity placing, as noted above or a wider equity placing that would require shareholder approval. The latter option would take more time but enable the Group to secure more funding than through a 10% direct equity placing. These events and conditions therefore indicate that a material uncertainty exists which may cast significant doubt on the Group's and Parent Company's ability to continue as a going concern and therefore their ability to realise their assets and discharge their liabilities in the ordinary course of business. These financial statements do not include the adjustments that would be necessary should the Going Concern basis of preparation no longer be appropriate.

This position is consistent with that disclosed in its 2021 Annual Report.

3. Segmental reporting

The Group's segmental reporting shows the performance of each operating business separately from the central costs that remain unallocated.

· TPG Maritime designs, manufactures and supports life support systems for submarine programmes

· TPG Services delivers technical expertise to complex and critical programmes in the defence and aerospace sectors

 

Financial information is provided to the chief operating decision maker ('CODM') in line with this structure.

 

The segmental analysis is reviewed to operating profit. Other resources are shared across the Group.

 

The following is an analysis of the Group's revenue and results from the continuing operations by reportable segment.

TPG Maritime

TPG Services

Central unallocated

 costs

 

Group

 

Continuing Operations:

£'000

£'000

£'000

£'000

Six months to 30 June 2022

 

 

 

 

Revenue

10,021

14,309

-

24,330

Operating result

(334)

1,123

(1,067)

(278)

Depreciation, amortisation and impairment

565

354

69

988

Exceptional operating costs

57

23

519

599

Share based payments

-

-

6

6

Adjusted operating profit / (loss)1

288

1,500

(473)

1,315

TPG Maritime

TPG Services

 

Central unallocated

 costs

 

Group

 

Continuing Operations (restated)2:

£'000

£'000

£'000

£'000

Six months to 30 June 2021

 

 

 

 

Revenue

10,700

12,796

-

23,496

Operating result

131

354

(2,224)

(1,739)

Depreciation, amortisation and impairment

632

517

135

1,284

Acquisition-related costs

-

-

140

140

Exceptional operating costs

-

-

531

531

Share based payments

-

-

34

34

Movement in expected earn-out payments

-

-

631

631

Adjusted operating profit / (loss)1

763

871

(753)

881

 

TPG Maritime

TPG Services

 

Central unallocated

 costs

 

Group

 

Continuing Operations:

£'000

£'000

£'000

£'000

Year ended 31 December 2021

 

 

 

 

Revenue

18,459

25,796

-

44,255

Operating result

(4,393)

1,354

(4,461)

(7,500)

Depreciation, amortisation and impairment

1,840

1,008

281

3,129

Acquisition-related costs

-

-

(40)

(40)

Exceptional operating costs

86

-

1,789

1,875

Gain on disposal of assets

-

(23)

-

(23)

Share based payments

-

-

164

164

Movement in expected earn-out payments

-

-

830

830

Adjusted operating profit / (loss)1

(2,467)

2,339

(1,437)

(1,565)

 

1 Adjusted operating profit / (loss) is defined as operating result adjusted to add back depreciation of property, plant and equipment and right-of-use assets, amortisation of intangible assets and impairment gains or losses on non-current assets, acquisition consideration accounted for as employment costs owing to ongoing service conditions, any acquisition-related charges, share-based payment charges and exceptional operating costs. The directors believe this measure is more reflective of the underlying performance of the Group than equivalent Generally Accepted Accounting Practice ('GAAP') measures because it is excludes non-recurring exceptional and acquisition costs, non-cash items and is therefore a better proxy for underlying operating cash, providing shareholders and other users of the financial statements with the most representative year-on-year comparison of underlying operational performance attributable to shareholders.

2 The comparative segment for the six months to 30 June 2021 has been restated to present the segments in line with the financial statements to 31 December 2021

4. Income tax

The tax charge/(credit) for the period comprises

Six months

Six months

Year ended

ended

ended

31st December

30th June 2022

31st June 2021

2021

(unaudited)

(unaudited)

(audited)

£'0000

£'0000

£'0000

Loss on ordinary activities including discontinued operations

(246) 

(3,054) 

(20,409)

Current tax credit for the year

-

-

(25)

Adjustments in respect to prior year

(2)

(10)

(3)

Current tax

(2)

(10)

(28)

Deferred tax arising on amortisation of acquired intangibles

(89)

(112)

(31)

Deferred tax

(89)

(112)

(31)

Tax credit from continuing operations

(91)

(122)

(59)

Tax charge / (credit) from discontinued operations

64

(121)

(1,321)

Tax credit from continuing and discontinuing operations

(27)

(243)

(1,380)

 

 

 

 

Effective tax rate

11.0%

8.0%

6.8%

 

5. Loss per share

The calculation of the basic loss per share is based on the loss after tax for the period divided by the weighted average number of shares in issue during the period as follows: 

 

Six months ended

30 June 2022

(Unaudited)

 

Six months ended

30 June 2021

(Unaudited)

 

Year ended

31 December 2021

(Audited)

 

Number of shares

Number of shares

Number of shares

Weighted average shares in issue

779,178,719

779,178,719

779,178,719

 

The issue of additional shares on exercise of employee share options would decrease the basic loss per share and there is therefore no dilutive effect of employee share options.

 

6. Discontinued operations

Following review of the Group's strategy as noted in the market release dated 1 November 2021. Westek Technology Limited ('Westek'), Sapienza Consulting Holdings BV, including its subsidiaries ('Sapienza') and the Group's NorthStar operations have been identified as assets held for sale in line with IFRS 5 Assets Held for Sale and Discontinued Operations.

 

Westek makes up a significant percentage of the Engineering business segment's revenue and operating result, and a material percentage of Group's operating result and net assets. Furthermore, the business represents the Group's entire ruggedised electronics business and therefore represents a major line of business. Discussions are ongoing with a potential buyer.

 

Sapienza made up a significant percentage of the Consulting business segment's revenue, operating result and net assets and was disposed of on 12 July 2022. Furthermore, the business represented:

· the Group's entire manpower activity in Europe

· the Group's entire mainland European legal and people infrastructure

· the Group's entire business for the document management software, Eclipse.

 

NorthStar was a significant part of the Group's software operations in terms of revenue and adjusted operating profit/(loss) and was disposed of on 31 March 2022. The balance of the software operations is the Eclipse software suite of products sold by Sapienza. Eclipse and NorthStar have now been disposed as noted above, closing the Group's software business in its entirety.

 

The financial performance and cash flow information for these discontinued operations, including the discontinued operations of Northstar, disposed of on 31 March 2022 is as follows:

 

  

Six months ended

30 June

2022

 

(Unaudited)

 

Six months ended

30 June

2021

(Unaudited)

 

Year ended

31 December

2021

 

(Audited)

 

 

£'000

£'000

£'000

 

Revenue

8,200

8,696

18,674

Cost of sales

(6,270)

(7,125)

(15,500)

Gross profit

1,930

1,571

3,174

Administrative expenses

(2,141)

(2,741)

(4,998)

Impairment

620

-

(10,572)

Operating loss

409

(1,170)

(12,396)

Net finance costs

(34)

(16)

(63)

Profit / (loss) before taxation

375

(1,186)

(12,459)

Taxation credit

(64)

121

1,321

Loss for the period attributable to equity holders of the parent company

311

(1,065)

(11,138)

 

 

 

6. Discontinued operations (continued)

  

30 June

2022

 

(Unaudited)

 

31 December

2021

 

(Audited)

 

 

£'000

£'000

 

Assets classified as held for sale

Other intangible assets

1,445

1,482

Property, plant and equipment

 

110

137

Right-of-use assets

421

500

Inventory

431

303

Trade and other receivables

 

3,961

4,450

Amounts due to contract customers

1,372

1,298

Total assets of disposal group held for sale

 

7,740

8,170

Liabilities directly associated with assets classified as held for sale

Trade and other payables

1,753

1,707

Amounts due to contract customers

3,787

3,506

Taxation

5

15

Lease liabilities

585

663

Deferred tax liability

368

270

Provisions

144

165

Total liabilities of disposal group held for sale

 

6,642

6,326

 

Cashflows from / (used in) discontinued operations:

Net cash flows from operating activities

 

752

(1,120)

Net cash flows from investing activities

290

(546)

Net cash flows from financing activities

(145)

(217)

Effects of exchange rates on cash and cash equivalents

(12)

(10)

Net decrease in cash generated by discontinued operations company

885

(1,893)

 

7. Prior period adjustment

Following an intensive review of contracts within the TPG Maritime business during the latter part of 2021 and early part of 2022, it was found that forecast costs to completion estimates were understated and contractual transaction prices were overstated as they did not include provision of late delivery penalties where required under IFRS 15 at 31 December 2020. This resulted in a prior year adjustment to the 2020 numbers, fully disclosed in the 2021 full year results. The aforementioned 2020 corrections resulted in an overstatement of contract revenue-to-date at 30 June 2021. Management considers this to be a material error in line with IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors (paragraphs 41-43) and corrected the prior period in line with the requirements of the standard.

 

The principal accounting adjustment corrections at the 31 December 2020 that have impacted the 6-month period to 30 June 2021 are:

· Increase in forecast costs to completion on contracts. Revenue is recognised overtime in line with IFRS 15 Revenue Recognition using the input cost method. The increase in costs to completion has reduced revenue to be recognised for the six months to 30 June 2021. The reduction in revenue reduces the amounts recoverable from the customer at the reporting date.

· Inclusion of late delivery penalties existing within contractual terms. As above, revenue is recognised over time in line with IFRS 15. The impact of late delivery penalties reduces the amount of revenue to be recognised at the reporting date.

· The increase in forecast costs to completion and late delivery penalties has resulted in the requirement to recognise onerous contract provisions. The impact of the onerous contract provisions increases provisions at the reporting date.

 

The impact on figures originally reported in the financial statements for the six months to 30 June 2021 is shown below.

 

Six months to

30 June

2021

as originally stated

Adjustment in respect of discontinued operations

Prior period adjustment

Six months to

30 June

2021

restated

£'000

£'000

£'000

£'000

Income statement:

Revenue from continuing operations

33,772

(8,696)

(1,580)

23,496

Cost of sales

(25,702)

7,125

327

(18,250)

Gross profit from continuing operations

8,070

(1,571)

(1,253)

5,246

Administrative expenses

(9,976)

2,741

250

(6,985)

Operating loss from continuing operations

(1,906)

1,170

(1,003)

(1,739)

Net finance costs

(145)

16

-

(129)

Loss before taxation from continuing operations

(2,051)

1,186

(1,003)

(1,868)

Taxation

243

(121)

-

122

Loss after tax from continuing operations

(1,808)

1,065

(1,003)

(1,746)

 

 

7. Prior period adjustment (continued)

 

Six months to

30 June

2021

as originally stated

Adjustment in respect of discontinued operations

Prior period adjustment

Six months to

30 June

2021

restated

 

 

£'000

£'000

£'000

£'000

Statement of financial position:

Amounts due from contract customers

12,378

-

(3,729)

8,649

Total current assets

28,290

-

(3,729)

24,561

Total assets

59,293

-

(3,729)

55,564

Trade and other payables

(14,434)

-

26

(14,408)

Amounts due to contract customers

(5,310)

(50)

(5,360)

Total current liabilities

(20,363)

 

(24)

(20,387)

Provisions

(223)

(12)

(235)

Total non-current liabilities

(13,646)

 

(12)

(13,658)

Total liabilities

(34,009)

 

(36)

(34,045)

Net assets

25,284

 

(3,765)

21,519

Retained earnings

(1,672)

 

(3,765)

(5,437)

 

8. Related party transactions

Science Group plc is the largest shareholder in TP Group plc with a shareholding of 27.97%.

On 16 December 2021 the Company entered into a standby credit facility with its major shareholder Science Group plc. Martyn Ratcliffe and Peter Bertram recused themselves from this process due to a conflict of interest. The facility takes the form of a Revolving Credit facility of a sum up to £5 million for a period to 30 September 2023. The terms of the facility, which reflect the unsecured standby revolving nature of the arrangement, include a set-up fee of 3%, interest rate on drawn amounts of 1% per month and a rate of 0.4% per month of any undrawn amount, both subject to the Sterling Overnight Index Average remaining below 1%. The facility can be cancelled or refinanced by TP Group at any time and without penalty or early termination charges. The facility was utilised for short periods to provide liquidity, however was undrawn at 30 June 2022.

An interim management support service agreement was entered into with Science Group plc on 14th February 2022. Costs for the services provided are £50,000 per quarter.

 

9. Post balance sheet events

On 12 July 2022 the Group announced the disposal of the entire issued share capital of Sapienza Consulting Holdings BV to Serco Holdings Limited (a wholly owned subsidiary of Serco Group plc) for a cash consideration of c.€3.2m. On completion c.£1m of the c.£2m net proceeds was used to part repay the Group's £7m loan facility with HSBC Bank Plc thereby reducing it to c.£6.0m.

 

 

10. Critical accounting estimates and judgements

In preparing these interim financial statements, management has made judgements and estimates that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expense. Actual results may differ from these estimates. The significant judgements made by management in applying the Group's accounting policies and the key sources of estimation uncertainty were the same as those described in the last annual financial statements.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR PPUBABUPPGMU
Date   Source Headline
27th Jan 20237:00 amRNSCancellation - TP Group Plc
26th Jan 202310:16 amRNSForm 8.5 (EPT/NON-RI) - TP Group PLC
26th Jan 202310:05 amRNSScheme Effective
26th Jan 20237:30 amRNSSuspension - TP Group Plc
25th Jan 20239:20 amRNSForm 8.5 (EPT/NON-RI)
24th Jan 20232:21 pmRNSCourt Sanction of Scheme of Arrangement
24th Jan 20238:55 amRNSForm 8.5 (EPT/NON-RI)
23rd Jan 20235:30 pmRNSTP Group
20th Jan 20239:05 amRNSForm 8.5 (EPT/NON-RI)
19th Jan 20238:26 amRNSForm 8.5 (EPT/NON-RI)
18th Jan 202312:11 pmRNSForm 8.3 - TP Group plc
18th Jan 202312:09 pmRNSForm 8.3 - TP Group plc
18th Jan 20238:37 amRNSForm 8.5 (EPT/NON-RI)
17th Jan 20238:45 amRNSForm 8.5 (EPT/NON-RI)
16th Jan 202312:53 pmRNSForm 8.3 - TP Group plc
16th Jan 20238:40 amRNSForm 8.5 (EPT/NON-RI)
13th Jan 20239:03 amRNSForm 8.5 (EPT/NON-RI)
12th Jan 20238:46 amRNSForm 8.5 (EPT/NON-RI)
11th Jan 20239:38 amRNSForm 8.5 (EPT/NON-RI)
10th Jan 20239:11 amRNSForm 8.5 (EPT/NON-RI)
9th Jan 20238:36 amRNSForm 8.5 (EPT/NON-RI)
9th Jan 20237:00 amRNSRegulatory Clearance & Scheme Timetable Update
6th Jan 20238:25 amRNSForm 8.5 (EPT/NON-RI)
5th Jan 20238:17 amRNSForm 8.5 (EPT/NON-RI)
4th Jan 20239:14 amRNSForm 8.5 (EPT/NON-RI) - TP Group PLC
29th Dec 20223:04 pmRNSSale of Westek Technology Ltd.
29th Dec 20228:44 amRNSForm 8.5 (EPT/NON-RI)
22nd Dec 20228:56 amRNSForm 8.5 (EPT/NON-RI)
21st Dec 202212:22 pmRNSHolding(s) in Company
21st Dec 20229:22 amRNSForm 8.5 (EPT/NON-RI)
20th Dec 202211:10 amRNSForm 8.5 (EPT/NON-RI)
19th Dec 202210:23 amRNSForm 8.5 (EPT/NON-RI)
19th Dec 20229:29 amRNSForm 8.3 - TP Group PLC
15th Dec 20228:58 amRNSForm 8.5 (EPT/NON-RI)
14th Dec 20223:33 pmRNSResult of Court Meeting & General Meeting
14th Dec 202210:26 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 20228:34 amRNSForm 8.5 (EPT/NON-RI)
7th Dec 202210:46 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20228:54 amRNSForm 8.5 (EPT/NON-RI)
2nd Dec 202210:02 amRNSForm 8.5 (EPT/NON-RI)
1st Dec 20229:55 amRNSForm 8.5 (EPT/NON-RI)
1st Dec 20228:15 amRNSForm 8.3 -TP Group PLC
30th Nov 20228:54 amRNSForm 8.5 (EPT/NON-RI)
29th Nov 20228:14 amRNSForm 8.3 - TP GROUP PLC
28th Nov 20228:22 amRNSForm 8.3 - TP Group PLC
24th Nov 202210:39 amRNSForm 8.5 (EPT/NON-RI)
24th Nov 20228:28 amRNSForm 8.3 - TP GROUP PLC
23rd Nov 20228:48 amRNSForm 8.3 - TP GROUP PLC
22nd Nov 20229:45 amRNSForm 8.5 (EPT/NON-RI)
22nd Nov 20228:26 amRNSForm 8.3 - TP GROUP PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.